A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of Immunotherapy
Radiotherapy plays an important role in the definitive and adjuvant treatment of head and neck squamous cell carcinoma (HNSCC). However, standard courses of radiation therapy may contribute to the depletion of circulating lymphocytes and potentially attenuate optimal tumor antigen presentation that...
Guardado en:
Autores principales: | Re-I Chin, Joshua P. Schiff, Randall J. Brenneman, Hiram A. Gay, Wade L. Thorstad, Alexander J. Lin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/df324d6107dc4b3ba9dfbe648f441e7e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A two-stage genome-wide association study of radiation-induced acute toxicity in head and neck cancer
por: Elnaz Naderi, et al.
Publicado: (2021) -
Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck
por: Ammar Sukari, et al.
Publicado: (2015) -
Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma
por: Xuanli Xu, et al.
Publicado: (2021) -
Imaging Features of Postradiotherapy Changes in Head and Neck Cancers
por: Anisha Gehani, et al.
Publicado: (2021) -
Nutritional Status as a Predictive Biomarker for Immunotherapy Outcomes in Advanced Head and Neck Cancer
por: Meytal Guller, et al.
Publicado: (2021)